FIRST LINE TREATMENT

Clinical trials for FIRST LINE TREATMENT explained in plain language.

Never miss a new study

Get alerted when new FIRST LINE TREATMENT trials appear

Sign up with your email to follow new studies for FIRST LINE TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immune therapy trial targets Tough-to-Treat skin cancer

Disease control Recruiting now

This study is testing whether the immunotherapy drug cemiplimab can help control advanced basal cell carcinoma when used as the first treatment. The trial will enroll about 34 adults with locally advanced skin cancer that cannot be treated with surgery or radiation. Participants …

Matched conditions: FIRST LINE TREATMENT

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

FIRST LINE TREATMENT

Get alerted when new FIRST LINE TREATMENT trials appear

New immune therapy trial targets Tough-to-Treat skin cancer